Background Patients newly diagnosed with cancer represent a population at highest risk for
stroke. The objective of this systematic review and meta-analysis was to estimate the …

Hyponatraemia is common in patients with stroke and associated with adverse outcomes
and increased mortality risk. The present review presents the underlying causes and …

Patients with hematological diseases often experience cerebrovascular complications
including ischemic stroke, intracerebral and subarachnoid hemorrhage, microbleeds …

Цель исследования. Изучение различных аспектов цереброваскулярных заболеваний
(ЦВЗ) на фоне метаболического синдрома (МС). Материалы и методы. Проводили …

Although novel agents for multiple myeloma (MM) have a better response rate and survival
in both newly diagnosed and relapsed/refractory MM patients, concerns regarding the …

Background AL amyloidosis might increase the risk of thromboembolism and other plasma
cell dyscrasias; however, only a few reports have described the clinical features of …

Background: Multiple myeloma (MM) is associated with high morbidity and mortality, with
elevated rates of arterial thrombosis and venous thromboembolism (VTE) and ischemic …

Established guidelines exist for prevention and treatment of venous thromboembolism in
hematological malignancies, but none for arterial thromboembolism. However, arterial and …

Multiple myeloma (MM) is a hematologic malignancy characterized by clonal proliferation of
plasma cells in the bone marrow, often leading to various end-organ damages. Here, we …

Venous thromboembolism (VTE) is a potentially life-threatening condition that can be
associated with significant morbidity. Thrombosis and hematological diseases are …